Our Clinical Pharmacology Leads have key roles to play in influencing the discovery and
development of drugs. It is exciting, critical work and you could be part of it. Pfizer is a leader
in model-based drug development, and we are expanding its influence in target validation and
selection. We have an open position as Clinical Pharmacology Lead supporting our Oncology Clinical Pharmacology team with working on one of our full development assets. Clinical Pharmacology Leads are also responsible for planning and direction of clinical pharmacology components of clinical programs (including clinical development plan/life cycle plan) and studies (including protocol preparation; clinical phase oversight, and reporting).
Act as Clinical Pharmacology representative on Clinical Sub Team and Development Team as
• Participate in implementing model based drug development using quantitative approaches to
address complex questions arising during drug development spanning from target validation to
analysis and interpretation of Phase II results.
• Responsible for providing the clinical pharmacology components of Clinical Plans and
provides clinical pharmacology expertise to the project team including plan, design and oversee
clinical pharmacology studies with operational assistance from operations colleagues
• Fully knowledgeable about the clinical pharmacology profile of allocated drugs on which studies are being conducted or which are called for in the protocol.
• Coordinates with medical writers (and other team members) in the data review, analysis and
reporting of the CP study. Responsible, in conjunction with medical writer, for overall content
and accuracy of study report before forwarding for final sign-off.
• Accountable and responsible for non-compartmental analysis of PK data and accountable for
ensuring appropriate PK-PD analysis including population PK, PK-PD modeling and simulation,
• Directs the planning of all relevant PK-PD analyses. Responsible for use of innovative
analytical methods to integrate knowledge of pharmacokinetics, pharmacodynamics, patient
characteristics and disease states to optimize doses, dosage regimens and study designs
throughout clinical drug development in collaboration with pharmacometrics and statistics (as
• Provides recommendations for clinical doses and dosing algorithms (including drug interaction
advice, food effects, special group dosing etc) to the clinical and Development teams and in
• Leads clinical pharmacology contributions to all regulatory documents including Investigator
Brochures, EOP2 meetings. Leads the resolution of clinical pharmacology queries from drug
regulatory agencies, takes a lead role in writing and reviewing responses to regulatory queries.
• Provides Clinical Pharmacology expertise to Discovery. During the pre-clinical stages of drug
development works with Research to ensure quantitative mechanistic understanding and
preclinical PK-PD knowledge exist to underwrite human administration.
• Accountable for ensuring that there are valid methods for measuring drug concentration (and
any biochemical biomarkers) in the clinic.
• May participate in multidisciplinary teams in assessing potential in-licensing opportunities, as
requested by line management.
• May act as clinician for phase I studies or clinical lead / research project lead for specific drug
Strong quantitative skills and expertise (e.g. experience in mechanistic PKPD modeling/systems
pharmacology, literature meta-analyses, population modeling, and clinical trial simulations)
• PhD in Clinical Pharmacology, Pharmacokinetics, Pharmacometrics, Engineering or other
suitable post-graduate qualification
• 3-5 years of industry experience in clinical pharmacology and/or clinical PK/PD and/or
• Excellent written and verbal communication skills
• Demonstrated presentation skills
Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.